4.6 Article

Genomic Analysis of Molecular Bacterial Mechanisms of Resistance to Phage Infection

期刊

FRONTIERS IN MICROBIOLOGY
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fmicb.2021.784949

关键词

bacterial; resistance; genomic island; phages; Acinetobacter baumannii; CRISPR; WGS or whole-genome sequencing

资金

  1. State Plan for RCDCI 2013-2016 (National Plan for Scientific Research, Technological Development and Innovation 2008-2011) [PI16/01163, PI19/00878]
  2. ISCIII-Deputy General Directorate of evaluation and Promotion of Research-European Regional Development Fund A way of Making Europe
  3. Instituto de Salud Carlos III FEDER
  4. Miguel Servet Research Programme (SERGAS)
  5. Miguel Servet Research Programme (ISCIII)

向作者/读者索取更多资源

This study analyzed the phage resistance in Acinetobacter baumannii clinical strains using genomic sequencing. The presence of genes associated with phage resistance was found to be higher in 2010 strains compared to 2000 strains, especially genes related to the restriction-modification system and CRISPR-Cas system. Furthermore, these genes were more frequently found in genomic islands of the 2010 strains.
To optimize phage therapy, we need to understand how bacteria evolve against phage attacks. One of the main problems of phage therapy is the appearance of bacterial resistance variants. The use of genomics to track antimicrobial resistance is increasingly developed and used in clinical laboratories. For that reason, it is important to consider, in an emerging future with phage therapy, to detect and avoid phage-resistant strains that can be overcome by the analysis of metadata provided by whole-genome sequencing. Here, we identified genes associated with phage resistance in 18 Acinetobacter baumannii clinical strains belonging to the ST-2 clonal complex during a decade (Ab2000 vs. 2010): 9 from 2000 to 9 from 2010. The presence of genes putatively associated with phage resistance was detected. Genes detected were associated with an abortive infection system, restriction-modification system, genes predicted to be associated with defense systems but with unknown function, and CRISPR-Cas system. Between 118 and 171 genes were found in the 18 clinical strains. On average, 26% of these genes were detected inside genomic islands in the 2000 strains and 32% in the 2010 strains. Furthermore, 38 potential CRISPR arrays in 17 of 18 of the strains were found, as well as 705 proteins associated with CRISPR-Cas systems. A moderately higher presence of these genes in the strains of 2010 in comparison with those of 2000 was found, especially those related to the restriction-modification system and CRISPR-Cas system. The presence of these genes in genomic islands at a higher rate in the strains of 2010 compared with those of 2000 was also detected. Whole-genome sequencing and bioinformatics could be powerful tools to avoid drawbacks when a personalized therapy is applied. In this study, it allows us to take care of the phage resistance in A. baumannii clinical strains to prevent a failure in possible phage therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Microbiology

Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host

L. Blasco, I Bleriot, M. Gonzalez de Aledo, L. Fernandez-Garcia, O. Pacios, H. Oliveira, M. Lopez, C. Ortiz-Cartagena, F. Fernandez-Cuenca, A. Pascual, L. Martinez-Martinez, J. Pachon, J. Azeredo, M. Tomas

Summary: The emergence of multidrug resistant bacteria has led to the need for alternatives to antibiotic therapy, and phage therapy has been identified as a potential solution. In this study, the adaptation process was used to develop a phage specifically targeting Acinetobacter baumannii. The adapted phage demonstrated an increased host range and expressed a depolymerase, which enhanced its antimicrobial activity. When combined with another phage, the phage cocktail showed strong antimicrobial and antibiofilm activity against A. baumannii strains.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Virology

Phenotypic and Genomic Comparison of Klebsiella pneumoniae Lytic Phages: vB_KpnM-VAC66 and vB_KpnM-VAC13

Olga Pacios, Laura Fernandez-Garcia, Ines Bleriot, Lucia Blasco, Anton Ambroa, Maria Lopez, Concha Ortiz-Cartagena, Felipe Fernandez Cuenca, Jesus Oteo-Iglesias, Alvaro Pascual, Luis Martinez-Martinez, Pilar Domingo-Calap, Maria Tomas

Summary: Klebsiella pneumoniae is a pathogen that worsens the prognosis of immunocompromised patients. Two lytic phages infecting clinical strains of K. pneumoniae (vB_KpnM-VAC13 and vB_KpnM-VAC66) were compared and annotated, with phenotypic characterization of vB_KpnM-VAC66. Genomic analysis showed similarities and differences between the two phages, with potential for therapeutic applications in addressing multidrug resistant pathogens.

VIRUSES-BASEL (2022)

Article Multidisciplinary Sciences

The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection

Ines Bleriot, Lucia Blasco, Olga Pacios, Laura Fernandez-Garcia, Anton Ambroa, Maria Lopez, Concha Ortiz-Cartagena, Felipe Fernandez Cuenca, Jesus Oteo-Iglesias, Alvaro Pascual, Luis Martinez-Martinez, Pilar Domingo-Calap, Thomas K. Wood, Maria Tomas

Summary: This study demonstrates the important role of the PemK/PemI TA system in phage inhibition. Overexpression of the PemK toxin leads to dormancy of bacteria, resulting in inhibition of phage infections.

SCIENTIFIC REPORTS (2022)

Review Microbiology

Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain

Roberto Vazquez, Roberto Diez-Martinez, Pilar Domingo-Calap, Pedro Garcia, Diana Gutierrez, Maite Muniesa, Maria Ruiz-Ruigomez, Rafael Sanjuan, Maria Tomas, Maria Angeles Tormo-Mas, Pilar Garcia

Summary: Antibiotic resistance is a major challenge for humanity, and phage therapy is being considered as an alternative to antibiotics. However, the development of antibiotics hindered the wide application of phage therapy in the West. Nevertheless, due to the rise of antimicrobial resistance, phage therapy is experiencing a revival, and some countries are adopting regulations to promote its short-term implementation in clinical practice. The Phage Therapy Work Group from FAGOMA in Spain has contacted the Spanish Drugs and Medical Devices Agency to advocate for the regulation of phage therapy in the country.

MICROORGANISMS (2022)

Article Multidisciplinary Sciences

Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents

Lucia Blasco, Manuel Gonzalez de Aledo, Concha Ortiz-Cartagena, Ines Bleriot, Olga Pacios, Maria Lopez, Laura Fernandez-Garcia, Antonio Barrio-Pujante, Marta Hernandez-Garcia, Rafael Canton, Maria Tomas

Summary: Phage tail-like bacteriocins (PTLBs) are large proteomic structures that function in bacterial competition by making pores in the membrane of competitors. PTLBs identified in Pseudomonas aeruginosa are known as R-type and F-type pyocins, which have a narrow spectrum of action determined by the tail fiber and related to the lipopolysaccharide type of the target competitor strain.

SCIENTIFIC REPORTS (2023)

Article Microbiology

Proteomic Study of the Interactions between Phages and the Bacterial Host Klebsiella pneumoniae

Ines Bleriot, Lucia Blasco, Olga Pacios, Laura Fernandez-Garcia, Maria Lopez, Concha Ortiz-Cartagena, Antonio Barrio-Pujante, Felipe Fernandez-Cuenca, Alvaro Pascual, Luis Martinez-Martinez, Jesus Oteo-Iglesias, Maria Tomas

Summary: In this study, the proteins isolated from 21 novel lytic phages of Klebsiella pneumoniae were analyzed to search for defense mechanisms against bacteria and to determine the infective capacity of the phages. Moreover, the defense mechanisms of clinical isolates of K. pneumoniae infected by phages were investigated through a proteomic study. The findings of this study provide insight into the molecular mechanisms involved in the phage-host bacterial interactions and highlight the importance of further research in this field.

MICROBIOLOGY SPECTRUM (2023)

Article Medicine, General & Internal

Case report: Analysis of phage therapy failure in a patient with a Pseudomonas aeruginosa prosthetic vascular graft infection

Lucia Blasco, Inmaculada Lopez-Hernandez, Miguel Rodriguez-Fernandez, Javier Perez-Florido, Carlos S. Casimiro-Soriguer, Sarah Djebara, Maya Merabishvili, Jean-Paul Pirnay, Jesus Rodriguez-Bano, Maria Tomas, Luis Eduardo Lopez Cortes

Summary: This article describes a case study of a patient with a multidrug-resistant prosthetic vascular graft infection caused by Pseudomonas aeruginosa, which was successfully treated with a combination of phages (PT07, 14/01, and PNM) and ceftazidime-avibactam (CZA). After phage therapy, a new infection with a wild-type strain of P. aeruginosa occurred, but this strain was susceptible to β-lactams and quinolones. Microbiology and whole genome sequencing techniques were used to analyze the clinical strains. The clinical isolates before and after phage therapy showed a clonal relationship with important genomic changes that may have contributed to resistance to this therapy. Phenotypic studies revealed a decrease in the Minimum Inhibitory Concentration (MIC) to β-lactams and quinolones, as well as an increase in biofilm production and phage-resistant mutants in the clinical isolate of P. aeruginosa after phage therapy.

FRONTIERS IN MEDICINE (2023)

Article Virology

Phage-Defense Systems Are Unlikely to Cause Cell Suicide

Laura Fernandez-Garcia, Thomas K. Wood

Summary: The overlap between phage-defense systems (PDs) and toxin/antitoxin systems (TAs) has become clear as new PDs are discovered, as both systems use similar means to reduce cellular metabolism. They both have members that deplete energetic compounds and nucleic acids, and inflict membrane damage. Additionally, both systems reduce host metabolism to limit phage propagation and interaction of multiple defense systems.

VIRUSES-BASEL (2023)

Article Microbiology

Prophage identification and molecular analysis in the genomes of Pseudomonas aeruginosa strains isolated from critical care patients

Manuel Gonzalez de Aledo, Lucia Blasco, Maria Lopez, Concha Ortiz-Cartagena, Ines Bleriot, Olga Pacios, Marta Hernandez-Garcia, Rafael Canton, Maria Tomas

Summary: This research aims to study the nature, composition, and role of prophages found within a set of circulating strains of Pseudomonas aeruginosa, with special attention to high-risk clones. Prophages have the ability to influence bacterial pathogenesis, making the basic research of prophages a topic of growing interest. The abundance of viral defense and regulatory proteins within prophage genomes detected in this study emphasizes the importance of characterizing the most frequent prophages in circulating clinical strains and in high-risk clones for potential phage therapy.

MSPHERE (2023)

Article Microbiology

CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases

Concha Ortiz-Cartagena, Daniel Pablo-Marcos, Laura Fernandez-Garcia, Lucia Blasco, Olga Pacios, Ines Bleriot, Maria Siller, Maria Lopez, Javier Fernandez, Belen Aracil, Pablo Arturo Fraile-Ribot, Sergio Garcia-Fernandez, Felipe Fernandez-Cuenca, Marta Hernandez-Garcia, Rafael Canton, Jorge Calvo-Montes, Maria Tomas

Summary: Carbapenems are crucial for combating multidrug-resistant pathogens. A new LAMP-CRISPR-Cas13a-based assay has been developed to detect OXA-48 and GES carbapenemases in clinical samples, offering rapid and accurate detection without the need for RNA extraction.

MICROBIOLOGY SPECTRUM (2023)

暂无数据